SIGA Technologies
SIGA
$8.95
Share price
1.94%
Change (1 day)
53.78%
Change (1 year)
Categories
SIGA Technologies (SIGA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $57.49 M
According to SIGA Technologies's latest financial reports the company's total liabilities are $57.49 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $57.49 M | 131.12% |
| 2022-12-31 | $24.87 M | -38.44% |
| 2021-12-31 | $40.41 M | 101.68% |
| 2020-12-31 | $20.03 M | -80.12% |
| 2019-12-31 | $0.10 B | 0.25% |
| 2018-12-31 | $0.10 B | -78.51% |
| 2017-12-31 | $0.46 B | 4.33% |
| 2016-12-31 | $0.44 B | -4.63% |
| 2015-12-31 | $0.47 B | 15.45% |
| 2014-12-31 | $0.40 B | 130.27% |
| 2013-12-31 | $0.17 B | 127.92% |
| 2012-12-31 | $77.59 M | 56.41% |
| 2011-12-31 | $49.6 M | 231.55% |
| 2010-12-31 | $14.96 M | -20.25% |
| 2009-12-31 | $18.76 M | 159.05% |
| 2008-12-31 | $7.24 M | 35.11% |
| 2007-12-31 | $5.36 M | -20.54% |
| 2006-12-31 | $6.74 M | 134.72% |
| 2005-12-31 | $2.87 M | 85.26% |
| 2004-12-31 | $1.55 M | 182.97% |
| 2003-12-31 | $0.54 M | -16.54% |
| 2002-12-31 | $0.65 M | -1.4% |
| 2001-12-31 | $0.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $2.40 B | 4,083.47% | 🇺🇸 USA |
 Novavax NVAX | $2.51 B | 4,273.37% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $36.45 M | -36.59% | 🇺🇸 USA |
 NanoViricides NNVC | $0.95 M | -98.35% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.97 B | 1,591.46% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.17 B | 1,941.78% | 🇺🇸 USA |